Hoe verhoudt EUQ's PS Ratio zich tot zijn concurrenten?

EUQ is duur op basis van de Price-To-Sales -ratio ( 15.1 x) vergeleken met het gemiddelde van de peer ( 9.3 x).

Hoe verhoudt EUQ's PS Ratio zich tot andere bedrijven in de DE Diversified Financial industrie?

EUQ is duur op basis van de Price-To-Sales -ratio ( 15.1 x) vergeleken met het German Diversified Financial -industriegemiddelde ( 1.9 x).

Wat is EUQ's PS Ratio vergeleken met zijn Fair PS Ratio? Dit is de verwachte PS Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

EUQ is duur op basis van de Price-To-Sales Ratio ( 15.1 x) vergeleken met de geschatte Fair Price-To-Sales Ratio ( 6 x).

Wat is de reële prijs van EUQ als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

EUQ ( €69.7 ) wordt verhandeld onder onze schatting van [[eerlijke waarde]] ( €449.54 )

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

De koersdoelstelling ligt meer dan 20 % hoger dan de huidige aandelenkoers en analisten zijn het statistisch gezien met elkaar eens.

Eurazeo (DB:EUQ) - Aandelenkoers, Nieuws & Analyse

EUQ Overzicht aandelen

EUQ fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	5/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	2/6

Beloningen

Verhandeld tegen 84.5% onder onze schatting van de reële waarde

De winst zal naar verwachting met 36.84% per jaar groeien

Analisten zijn het erover eens dat de aandelenkoers met 29.4% zal stijgen

Risicoanalyse

Het dividend van 3.42% wordt niet goed gedekt door de winst of de vrije kasstromen

Eurazeo SE Concurrenten

CHAPTERS Group

XTRA:CHG

€528.8m

Scherzer

XTRA:PZS

€65.3m

Tradegate Wertpapierhandelsbank

DB:T2G

€2.2b

Hypoport

XTRA:HYQ

€1.4b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Eurazeo
Historische aandelenkoersen
Huidige aandelenkoers	€69.70
52 Week Hoogtepunt	€86.10
52 Week Laag	€61.90
Bèta	1.39
11 maand verandering	-1.55%
3 maanden verandering	-1.83%
1 Jaar Verandering	11.70%
33 jaar verandering	-5.68%
5 jaar verandering	13.61%
Verandering sinds IPO	126.45%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	EUQ	DE Diversified Financial	DE Markt
7D	1.3%	-0.6%	0.8%
1Y	11.7%	5.0%	9.1%

Rendement versus industrie: EUQ overtrof de German Diversified Financial industrie, die het afgelopen jaar een rendement 4.8 % opleverde.

Rendement versus markt: EUQ overtrof de German markt, die het afgelopen jaar een rendement opleverde van 8.5 %.

Prijsvolatiliteit

Is EUQ's price volatile compared to industry and market?
EUQ volatility
EUQ Average Weekly Movement	2.6%
Diversified Financial Industry Average Movement	3.7%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: EUQ heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van EUQ is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1969	410	Christophe Baviere	www.eurazeo.com/en/

Eurazeo SE is een participatiemaatschappij gespecialiseerd in groeikapitaal, overnames, leveraged buyouts en buy-ins van een private onderneming, en investeringen in middelgrote en beursgenoteerde publieke ondernemingen. Het bedrijf investeert in aandelenkapitaal in de small-mid en mid-large buyout segmenten. Het bedrijf wil investeren in middelgrote of grote bedrijven, KMO's, snelgroeiende bedrijven en vastgoedbeheer en -beleggingsactiviteiten.

Eurazeo SE Samenvatting

Hoe verhouden de winst en inkomsten van Eurazeo zich tot de beurswaarde?
EUQ fundamentele statistieken
Marktkapitalisatie	€5.12b
Inkomsten(TTM)	-€77.36m
Inkomsten(TTM)	€337.89m

15.1x

P/S-verhouding

-66.1x

Koers/Winstverhouding

Is EUQ overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EUQ resultatenrekening (TTM)
Inkomsten	€337.89m
Kosten van inkomsten	€93.12m
Brutowinst	€244.77m
Overige uitgaven	€322.13m
Inkomsten	-€77.36m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-1.07
Brutomarge	72.44%
Nettowinstmarge	-22.90%
Schuld/Eigen Vermogen Verhouding	14.2%

Hoe presteerde EUQ op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.4%

Huidig dividendrendement

-223%

Uitbetalingsratio

EUQ Overzicht aandelen

Beloningen

Risicoanalyse

Eurazeo SE Concurrenten

XTRA:CHG

€528.8m

XTRA:PZS

€65.3m

DB:T2G

€2.2b

XTRA:HYQ

€1.4b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Upcoming dividend of €2.42 per share

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €62.80

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.80

New 90-day high: €56.85

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

New 90-day high: €55.90

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.